Trademark Overview
On Thursday, October 23, 2025, a trademark application was filed for XECCAPSMA with the United States Patent and Trademark Office. The USPTO has given the XECCAPSMA trademark a serial number of 79442196. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 29, 2026. This trademark is owned by Cellbion Co., Ltd.. The XECCAPSMA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations; radiopharmaceuticals; radioactive materials for medical purposes; sealed radioactive substances for medical purposes; radioactive elements for medical use; radiological contrast substances for medical purposes; radiopharmaceutical preparations for diagnostic purposes; radioisotope markers for therapeutic or diagnostic use; radiopharmaceuticals for treatment of prostate cancer; radiopharmaceuticals for cancer treatment; radioactive pharmaceuticals; radioactive therapeutic pharmaceuticals; pharmaceutical preparations for treatment of metastatic cancer; nuclear medicine therapeutic preparations; pharmaceutical preparations for cancer treatment; contrast agents for nuclear medicine imaging and therapy; prostate cancer-targeting agents; peptide-based radiolabeled agents for therapeutic or diagnostic use.
